A Polish Radio piece on the oral version of Wegovy and what it does for weight loss. Little detail came through beyond the topic itself.
Recap by typeshit. Full story at www2.polskieradio.pl.
A retrospective study in Cureus looks back at how well once-weekly semaglutide worked, and how safe it was, for teenagers with obesity.
Presented at Sleep Europe 2026, both trials found retatrutide lowered the apnea-hypopnea index more than placebo, including in people with type 2 diabetes.
Endpoints News
Endpoints reports Eli Lilly is building a case for its triple agonist beyond obesity, where a launch is expected next year, with sleep apnea next in line.
Observational data link GLP-1 drugs to fewer cases of some cancers, but trials have yet to show they prevent cancer or help survival after a diagnosis.
Lilly is widening its legal push against the black market for its experimental obesity shot, which still has no approval.
An indirect comparison found 1.46 points more weight loss than 25 mg Rybelsus at 52 weeks. GlobalData's analyst says head-to-head trials are still needed.
Loading…